{
    "subsubsector": "Pharmaceuticals",
    "subsector": "Pharmaceuticals, Biotechnology & Life Sciences",
    "id": "health-care-pharmaceuticals-biotechnology-life-sciences-pharmaceuticals",
    "criteria": [
        {
            "name": "R&D Investment",
            "description": "The amount invested in research and development to discover new drugs and therapies.",
            "importance_rank": "High",
            "reason": "Research and development are crucial for innovation and staying competitive in the pharmaceutical industry.",
            "examples": [
                "Investment in developing new diabetes medications",
                "Funding for cancer research trials"
            ],
            "data_points": [
                {
                    "name": "Annual R&D Expenditure",
                    "description": "Total investment in R&D activities per year",
                    "source": "Company financial reports"
                },
                {
                    "name": "Number of Clinical Trials",
                    "description": "The count of clinical trials initiated in a given year",
                    "source": "ClinicalTrials.gov"
                }
            ],
            "normalized_data_points": [
                {
                    "name": "R&D Spend per Revenue",
                    "formula": "Total R&D Spend / Total Revenue",
                    "unit": "Percentage"
                },
                {
                    "name": "R&D Cycle Time",
                    "formula": "Average Time to Bring Drug to Market (Years)",
                    "unit": "Years"
                }
            ],
            "benchmarks": [
                {
                    "metric": "R&D to Revenue Ratio",
                    "ideal_value": "15% or higher",
                    "range": "10% - 20%"
                }
            ],
            "companies": [
                {
                    "name": "Pfizer Inc.",
                    "ticker": "PFE",
                    "market_cap": "$220B",
                    "revenue": "$57B"
                },
                {
                    "name": "Johnson & Johnson",
                    "ticker": "JNJ",
                    "market_cap": "$450B",
                    "revenue": "$93B"
                }
            ],
            "key_points": [
                "Focus on long-term potential returns.",
                "Consider regulatory hurdles in R&D investment.",
                "Evaluate partnerships with research institutions.",
                "Assess the ratio of successful trials to investments.",
                "Review historical R&D trends for financial forecasting."
            ],
            "charts": [
                {
                    "type": "Bar Chart",
                    "usage": "Comparing R&D expenses over different periods or across companies for investment decisions."
                },
                {
                    "type": "Pie Chart",
                    "usage": "Visualizing R&D expenditure as a percentage of total revenue."
                }
            ]
        }
    ]
}